{"id":"https://openalex.org/W1978686299","doi":"https://doi.org/10.1159/000026621","title":"Effects of Serotonin-Selective and Classical Antidepressants on the Auditory P300 Cognitive Potential","display_name":"Effects of Serotonin-Selective and Classical Antidepressants on the Auditory P300 Cognitive Potential","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W1978686299","doi":"https://doi.org/10.1159/000026621","mag":"1978686299","pmid":"https://pubmed.ncbi.nlm.nih.gov/10559704"},"language":"en","primary_location":{"id":"doi:10.1159/000026621","doi":"https://doi.org/10.1159/000026621","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000026621","pdf_url":null,"source":{"id":"https://openalex.org/S147539111","display_name":"Neuropsychobiology","issn_l":"0302-282X","issn":["0302-282X","1423-0224"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978686299"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051755102","display_name":"Xavier Liogier D\u2019ardhuy","orcid":"https://orcid.org/0009-0005-5994-6487","observed_orcids":["https://orcid.org/0009-0005-5994-6487"]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"X. Liogier d\u2019Ardhuy","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, France. xavier.liogier@forenap.asso.fr","FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, France. xavier.liogier@forenap.asso.fr","institution_ids":["https://openalex.org/I4210103368"]},{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071958702","display_name":"Peter H. Boeijinga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P.H. Boeijinga","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073143862","display_name":"Bernard Renault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405274105","display_name":"Unit\u00e9 de psychophysiologie cognitive","ror":"https://ror.org/012zegf27","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I39804081","https://openalex.org/I4405264447","https://openalex.org/I4405274105"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Renault","raw_affiliation_strings":["CNRS URA 654 LENA, H\u00f4pital de la Salp\u00eatri\u00e8re, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS URA 654 LENA, H\u00f4pital de la Salp\u00eatri\u00e8re, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210121705","https://openalex.org/I4405274105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089587823","display_name":"R. Luthringer","orcid":"https://orcid.org/0000-0002-2819-1238","observed_orcids":["https://orcid.org/0000-0002-2819-1238"]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"R. Luthringer","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062221141","display_name":"Gilbert Rinaudo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Rinaudo","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027437841","display_name":"Laurent Soufflet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Soufflet","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Toussaint","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Toussaint","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113572516","display_name":"J.P. Macher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103368","display_name":"Centre hospitalier de Rouffach","ror":"https://ror.org/01extmz43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210103368"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.-P. Macher","raw_affiliation_strings":["FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FORENAP, Institute for Research in Neurosciences, Neuropharmacology and Psychiatry, Centre Hospitalier, Rouffach, and","institution_ids":["https://openalex.org/I4210103368"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6306,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.5897304,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"40","issue":"4","first_page":"207","last_page":"213"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5059000253677368,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5059000253677368,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.388700008392334,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10042","display_name":"Neural and Behavioral Psychology Studies","score":0.06289999932050705,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p300","display_name":"P300","score":0.9430000185966492},{"id":"https://openalex.org/keywords/auditory-oddball-paradigm","display_name":"auditory oddball paradigm","score":0.7020000219345093},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8159999847412109},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9330000281333923},{"id":"https://openalex.org/keywords/tianeptine","display_name":"tianeptine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":1.0},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.703000009059906},{"id":"https://openalex.org/keywords/n2-component","display_name":"N2 component","score":0.8870000243186951},{"id":"https://openalex.org/keywords/event-related-potentials","display_name":"event-related potentials","score":0.6679999828338623},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.6050000190734863},{"id":"https://openalex.org/keywords/monoaminergic-systems","display_name":"monoaminergic systems","score":0.7329999804496765},{"id":"https://openalex.org/keywords/cholinergic-system","display_name":"cholinergic system","score":0.9819999933242798}],"concepts":[{"id":"https://openalex.org/C2776903192","wikidata":"https://www.wikidata.org/wiki/Q424260","display_name":"Tianeptine","level":4,"score":0.7915937900543213},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.6518032550811768},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6322938799858093},{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.5914713740348816},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.5580478310585022},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5358062982559204},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.496175616979599},{"id":"https://openalex.org/C42251903","wikidata":"https://www.wikidata.org/wiki/Q18391002","display_name":"Monoaminergic","level":4,"score":0.4960554540157318},{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.45718711614608765},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32452571392059326},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.30810546875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2942609190940857},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2121793031692505},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.16939204931259155},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005072","descriptor_name":"Evoked Potentials, Auditory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013841","descriptor_name":"Thiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018913","descriptor_name":"Event-Related Potentials, P300","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000026621","doi":"https://doi.org/10.1159/000026621","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000026621","pdf_url":null,"source":{"id":"https://openalex.org/S147539111","display_name":"Neuropsychobiology","issn_l":"0302-282X","issn":["0302-282X","1423-0224"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"journal-article"},{"id":"pmid:10559704","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10559704","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W124408300","https://openalex.org/W157624765","https://openalex.org/W1928975456","https://openalex.org/W1965234746","https://openalex.org/W1966747636","https://openalex.org/W1983258883","https://openalex.org/W1994702289","https://openalex.org/W2001572659","https://openalex.org/W2008060633","https://openalex.org/W2016204166","https://openalex.org/W2025478718","https://openalex.org/W2033385903","https://openalex.org/W2046247411","https://openalex.org/W2063281437","https://openalex.org/W2070139468","https://openalex.org/W2070578579","https://openalex.org/W2079035297","https://openalex.org/W2096592429","https://openalex.org/W2144939326","https://openalex.org/W2409023596","https://openalex.org/W2415637990","https://openalex.org/W2473837822","https://openalex.org/W2513074826"],"related_works":["https://openalex.org/W2069299173","https://openalex.org/W2035099716","https://openalex.org/W1966141814","https://openalex.org/W3024551816","https://openalex.org/W2144939326","https://openalex.org/W4239231901","https://openalex.org/W2364230316","https://openalex.org/W2774021726","https://openalex.org/W2156134256","https://openalex.org/W1978908541"],"abstract_inverted_index":{"The":[0],"cognitive":[1],"potential,":[2],"P300,":[3],"is":[4],"a":[5,189,214],"phenomenon":[6],"frequently":[7],"studied":[8],"in":[9,55,60,163,174,217,226],"relation":[10],"to":[11,130,136],"template":[12],"matching":[13],"of":[14,22,29,47,64,85,97,111,192,220,229],"the":[15,19,27,50,82,88,141,148,155,164,218,227],"brain.":[16],"To":[17],"understand":[18],"neurochemical":[20],"mechanisms":[21],"its":[23],"generation,":[24],"we":[25],"compared":[26],"effects":[28,201],"three":[30,61],"antidepressants,":[31],"fluoxetine,":[32],"tianeptine":[33,149],"and":[34,38,52,73,93,101,166,204],"clomipramine":[35,74,119],"after":[36,44,115,147],"single":[37,69],"repeated":[39],"application":[40],"as":[41,43],"well":[42],"1":[45,145],"week":[46],"withdrawal":[48],"on":[49,125,151,202,205],"P300":[51,86,193],"N200":[53],"waves":[54],"an":[56],"auditory":[57],"'odd-ball'":[58],"paradigm":[59],"parallel":[62],"groups":[63],"10":[65],"healthy":[66],"volunteers.":[67],"Following":[68],"administration,":[70],"both":[71],"fluoxetine":[72,92,160],"reduced":[75,95],"(-39":[76],"+/-":[77,99,103],"14%,":[78],"p":[79],"<":[80],"0.01)":[81],"peak":[83,175],"amplitude":[84,194],"at":[87,140],"Pz":[89],"electrode.":[90],"For":[91],"tianeptine,":[94],"amplitudes":[96],"19":[98],"7%":[100],"24":[102],"11%,":[104],"respectively,":[105],"were":[106,161],"found":[107,124],"following":[108],"8":[109,127],"days":[110],"treatment,":[112],"2":[113],"h":[114,146],"administration.":[116],"However,":[117],"for":[118],"no":[120],"additional":[121,200],"diminution":[122],"was":[123],"day":[126,131,152],"with":[128],"respect":[129],"1.":[132],"Topographic":[133],"distributions":[134],"tended":[135],"be":[137,182],"significantly":[138],"modified":[139],"frontal":[142],"scalp":[143,169],"area":[144],"administration":[150],"8,":[153],"whereas":[154],"postdosing":[156],"changes":[157],"induced":[158],"by":[159],"localised":[162],"midline":[165],"right":[167],"centrotemporal":[168],"regions.":[170],"Only":[171],"minor":[172],"reductions":[173],"latencies":[176],"have":[177,188],"been":[178],"observed.":[179],"It":[180],"can":[181],"concluded":[183],"that":[184,211],"serotonin":[185,212],"selective":[186],"drugs":[187],"slower":[190],"onset":[191],"decrease":[195],"than":[196],"clomipramine,":[197],"which":[198,223],"has":[199,213],"monoaminergic":[203],"cholinergic":[206],"systems.":[207],"These":[208],"results":[209],"suggest":[210],"regulatory":[215],"function":[216],"neurotransmission":[219],"cerebral":[221],"structures":[222],"are":[224],"involved":[225],"evaluation":[228],"stimulus":[230],"relevance.":[231]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}